bioRxivNeurosciencePreprint
A functional interaction between TDP-43 and USP10 reveals USP10 dysfunction in TDP-43 proteinopathies
Alessandro Marrero‐GagliardiiD, Judith NodaiD, Matteo ZanovelloiD, G Gerenu, José Miguel Brito ArmasiD, Alexander BamptoniD, Pascual TorresiD, Haizea Hernández-EguiazuiD, S Moragón, F Pellegrini, C Pérez Hernández, Felipe Fumagallo-ReadingiD, L Taoro-González, R Muñoz de Bustillo Alfaro, Anna‐Leigh BrowniD, Grégoire QuinetiD, Pol Andrés‐BenitoiD, Isidró FerreriD, Ángel AcebesiD, Raimundo FreireiD, VAJ Smits, FJ Gil-Bea, Matthew J. KeussiD, Manuel Portero‐OtíniD, Tammaryn LashleyiD, , Abraham Acevedo‐ArozenaiD
Abstract
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal neurodegenerative disorders characterised by the progressive degeneration of specific neurons, that are defined by the appearance of TDP-43 pathology leading to TDP-43 cytoplasmic aggregation coupled with its nuclear loss. Although the causes of TDP-43 pathology in TDP-43 proteinopathies remain unclear, stress response may play a significant role, with some TDP-43 co-localizing with stress granules (SG). The ubiquitin-specific protease 10 (USP10) is a critical inhibitor of SG assembly. Here, we identify a new functional interaction between TDP-43 and USP10, with both proteins modulating different key aspects of the biology of the other. Adding to their functional connection, we assign a new function to USP10 as a modulator of alternative splicing, sharing a subset of splicing targets with TDP-43. Critically, we found that USP10 levels can increase in postmortem tissue from ALS and FTD patients and that USP10 can ameliorate TDP-43 mediated toxicity in vivo in an animal model, overall suggesting a new role for USP10 in TDP-43 proteinopathies.
- organism: human
- assay: proteomics
- research focus: protein structure prediction
- research focus: protein design
- research focus: drug response / drug discovery
- research focus: perturbation response prediction
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ubiquitin Proteasome System Components, RAD23A and USP13, Modulate TDP-43 Solubility and Neuronal Toxicity
Casey Dalton, Jelena Mojsilovic‐Petrovic, … Robert Gordon Kalb·Journal of NeurosciencePeer-reviewed·Dec 10, 2025
- TDP-43 toxic gain of function links ALS, FTD and Alzheimers Disease through splicing dysregulation
Welmoed van Zuiden, Thea Deborah Meimoun, … Eran Hornstein·bioRxiv·Apr 20, 2025
- Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLD
Longxin Xie, Yuehua Zhu, … Christopher J. Donnelly·bioRxiv·Apr 7, 2025
- Protein disulfide isomerase disassembles stress granules and blocks cytoplasmic aggregation of TDP-43 in ALS
Jia‐Qi Liu, Hao Liu, … Yi Liang·Advanced SciencePeer-reviewed·May 25, 2026
- Cdc48/VCP and endocytosis regulate TDP-43 and FUS toxicity and turnover
Guangbo Liu, Aaron T. Byrd, … J. Ross Buchan·Molecular and Cellular BiologyPeer-reviewed·Nov 22, 2019
- Tryptophan residues in TDP-43 and SOD1 mediate the cross-seeding and toxicity of SOD1
E. Pokrishevsky, M. G. Duval, … N. R. Cashman·bioRxiv·Jul 27, 2020